Halozyme Therapeutics, Inc. (HALO)
108.64
+0.47
(+0.43%)
USD |
NASDAQ |
Aug 24, 16:00
108.64
0.00 (0.00%)
After-Hours: 19:56
Halozyme Therapeutics Total Assets (Quarterly) : 2.577B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.577B |
| March 31, 2026 | 2.673B |
| December 31, 2025 | 2.714B |
| September 30, 2025 | 2.221B |
| June 30, 2025 | 2.054B |
| March 31, 2025 | 2.197B |
| December 31, 2024 | 2.164B |
| September 30, 2024 | 2.118B |
| June 30, 2024 | 1.969B |
| March 31, 2024 | 1.842B |
| December 31, 2023 | 1.733B |
| September 30, 2023 | 1.893B |
| June 30, 2023 | 1.810B |
| March 31, 2023 | 1.699B |
| December 31, 2022 | 1.842B |
| September 30, 2022 | 1.865B |
| June 30, 2022 | 1.781B |
| March 31, 2022 | 1.162B |
| December 31, 2021 | 1.104B |
| September 30, 2021 | 1.185B |
| June 30, 2021 | 1.026B |
| March 31, 2021 | 966.58M |
| December 31, 2020 | 579.92M |
| September 30, 2020 | 524.03M |
| June 30, 2020 | 527.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 492.35M |
| December 31, 2019 | 565.87M |
| September 30, 2019 | 370.36M |
| June 30, 2019 | 417.83M |
| March 31, 2019 | 429.11M |
| December 31, 2018 | 440.25M |
| September 30, 2018 | 444.51M |
| June 30, 2018 | 474.75M |
| March 31, 2018 | 495.47M |
| December 31, 2017 | 519.94M |
| September 30, 2017 | 357.15M |
| June 30, 2017 | 344.79M |
| March 31, 2017 | 226.77M |
| December 31, 2016 | 261.52M |
| September 30, 2016 | 282.50M |
| June 30, 2016 | 296.13M |
| March 31, 2016 | 309.10M |
| December 31, 2015 | 181.79M |
| September 30, 2015 | 158.73M |
| June 30, 2015 | 174.05M |
| March 31, 2015 | 159.12M |
| December 31, 2014 | 165.98M |
| September 30, 2014 | 164.63M |
| June 30, 2014 | 182.05M |
| March 31, 2014 | 197.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Incyte Corp. | 7.873B |
| Neurocrine Biosciences, Inc. | 5.359B |
| AVITA Medical, Inc. | 47.78M |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.434B |
| Shareholders Equity (Quarterly) | 143.54M |
| Debt to Equity Ratio | 14.95 |
| Current Ratio | 2.709 |
| Net Debt Paydown Yield | -1.43% |